271 related articles for article (PubMed ID: 22527214)
1. [Cryopyrin-associated periodic syndrome].
Kümmerle-Deschner JB
Z Rheumatol; 2012 Apr; 71(3):199-208. PubMed ID: 22527214
[TBL] [Abstract][Full Text] [Related]
2. Canakinumab in patients with cryopyrin-associated periodic syndrome: an update for clinicians.
Kuemmerle-Deschner JB; Haug I
Ther Adv Musculoskelet Dis; 2013 Dec; 5(6):315-29. PubMed ID: 24294305
[TBL] [Abstract][Full Text] [Related]
3. [Cryopyrin-associated periodic syndromes].
Quartier P; Rodrigues F; Georgin-Lavialle S
Rev Med Interne; 2018 Apr; 39(4):287-296. PubMed ID: 29111302
[TBL] [Abstract][Full Text] [Related]
4. CAPS--pathogenesis, presentation and treatment of an autoinflammatory disease.
Kuemmerle-Deschner JB
Semin Immunopathol; 2015 Jul; 37(4):377-85. PubMed ID: 25963520
[TBL] [Abstract][Full Text] [Related]
5. Successful management of cryopyrin-associated periodic syndrome with canakinumab in infancy.
Kanariou M; Tantou S; Varela I; Raptaki M; Petropoulou C; Nikas I; Valari M
Pediatrics; 2014 Nov; 134(5):e1468-73. PubMed ID: 25349319
[TBL] [Abstract][Full Text] [Related]
6. [Papillary edema in Muckle-Wells syndrome].
Wirths G; Grenzebach U; Eter N
Ophthalmologe; 2015 Sep; 112(9):778-82. PubMed ID: 25614348
[TBL] [Abstract][Full Text] [Related]
7. Long term management of patients with cryopyrin-associated periodic syndromes (CAPS): focus on rilonacept (IL-1 Trap).
Church LD; Savic S; McDermott MF
Biologics; 2008 Dec; 2(4):733-42. PubMed ID: 19707454
[TBL] [Abstract][Full Text] [Related]
8. Rare Clinical Case of Cryopyrin-associated Periodic Syndrome Presented with Ankylosing Spondylitis: A Case Report.
Zayaeva AA; Sokolova LV; Shaduro DV; Petrov AV; Kulanthaivel S; Kaliberdenko VB
Curr Rheumatol Rev; 2022; 18(4):373-379. PubMed ID: 34784874
[TBL] [Abstract][Full Text] [Related]
9. Canakinumab (ACZ885, a fully human IgG1 anti-IL-1β mAb) induces sustained remission in pediatric patients with cryopyrin-associated periodic syndrome (CAPS).
Kuemmerle-Deschner JB; Ramos E; Blank N; Roesler J; Felix SD; Jung T; Stricker K; Chakraborty A; Tannenbaum S; Wright AM; Rordorf C
Arthritis Res Ther; 2011 Feb; 13(1):R34. PubMed ID: 21356079
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of cryopyrin-associated periodic syndrome: challenges, recommendations and emerging concepts.
Sarrabay G; Grandemange S; Touitou I
Expert Rev Clin Immunol; 2015; 11(7):827-35. PubMed ID: 25979514
[TBL] [Abstract][Full Text] [Related]
11. [Genetics of cryopyrin-associated periodic syndrome].
Kümmerle-Deschner JB; Lohse P
Z Rheumatol; 2017 May; 76(4):313-321. PubMed ID: 28197772
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological treatment options for cryopyrin-associated periodic syndromes.
Landmann EC; Walker UA
Expert Rev Clin Pharmacol; 2017 Aug; 10(8):855-864. PubMed ID: 28586272
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and Management of the Cryopyrin-Associated Periodic Syndromes (CAPS): What Do We Know Today?
Welzel T; Kuemmerle-Deschner JB
J Clin Med; 2021 Jan; 10(1):. PubMed ID: 33401496
[TBL] [Abstract][Full Text] [Related]
14. Necrotizing Funisitis as an Intrauterine manifestation of Cryopyrin-Associated Periodic Syndrome: a case report and review of the literature.
Yokoi K; Minamiguchi S; Honda Y; Kobayashi M; Kobayashi S; Nishikomori R
Pediatr Rheumatol Online J; 2021 May; 19(1):77. PubMed ID: 34059097
[TBL] [Abstract][Full Text] [Related]
15. Current treatment recommendations and considerations for cryopyrin-associated periodic syndrome.
Koné-Paut I; Galeotti C
Expert Rev Clin Immunol; 2015; 11(10):1083-92. PubMed ID: 26312542
[TBL] [Abstract][Full Text] [Related]
16. MRP8 and MRP14, phagocyte-specific danger signals, are sensitive biomarkers of disease activity in cryopyrin-associated periodic syndromes.
Wittkowski H; Kuemmerle-Deschner JB; Austermann J; Holzinger D; Goldbach-Mansky R; Gramlich K; Lohse P; Jung T; Roth J; Benseler SM; Foell D
Ann Rheum Dis; 2011 Dec; 70(12):2075-2081. PubMed ID: 21908452
[TBL] [Abstract][Full Text] [Related]
17. Cryopyrin-associated periodic fever syndrome in children: A case-based review.
Gupta A; Tripathy SK; Phulware RH; Arava S; Bagri NK
Int J Rheum Dis; 2020 Feb; 23(2):262-270. PubMed ID: 31858722
[TBL] [Abstract][Full Text] [Related]
18. Cryopyrin-associated periodic syndrome in Australian children and adults: Epidemiological, clinical and treatment characteristics.
Mehr S; Allen R; Boros C; Adib N; Kakakios A; Turner PJ; Rogers M; Zurynski Y; Singh-Grewal D
J Paediatr Child Health; 2016 Sep; 52(9):889-95. PubMed ID: 27650144
[TBL] [Abstract][Full Text] [Related]
19. Cryopyrin-associated periodic syndromes: otolaryngologic and audiologic manifestations.
Ahmadi N; Brewer CC; Zalewski C; King KA; Butman JA; Plass N; Henderson C; Goldbach-Mansky R; Kim HJ
Otolaryngol Head Neck Surg; 2011 Aug; 145(2):295-302. PubMed ID: 21493283
[TBL] [Abstract][Full Text] [Related]
20. Computational Modeling of NLRP3 Identifies Enhanced ATP Binding and Multimerization in Cryopyrin-Associated Periodic Syndromes.
Samson JM; Ravindran Menon D; Vaddi PK; Kalani Williams N; Domenico J; Zhai Z; Backos DS; Fujita M
Front Immunol; 2020; 11():584364. PubMed ID: 33329557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
